4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-026832
President & CEO sold 297,573 shares at an average $12.94 ($3,851,918)
- President & CEO acquired 297,573 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Stonehouse Jon P · President & CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-01 | Exercise or conversion : show line 1 in the form | +214,917 | $1.42 | $305,182 | 1,116,747 | D |
| 2022-12-01 | Sale : show line 2 in the form | −214,917 | $13.00 | $2,793,921 | 901,830 | D |
| 2022-12-02 | Exercise or conversion : show line 3 in the form | +82,656 | $1.42 | $117,372 | 984,486 | D |
| 2022-12-02 | Sale : show line 4 in the form | −82,656 | $12.80 | $1,057,997 | 901,830 | D |
| Open-market sales · 297,573 sh · avg $12.94 · $3,851,918 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-01 | Exercise or conversion : show line 5 in the form Emp. Stock Option (Right to Buy) | −214,917 | 82,656 | D |
| 2022-12-02 | Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) | −82,656 | 0 | D |
Loading xslF345X03/form4.xml…